000 01554 a2200409 4500
005 20250513084717.0
264 0 _c19960307
008 199603s 0 0 eng d
022 _a0143-3636
024 7 _a10.1097/00006231-199510000-00010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBard, D R
245 0 0 _aAn improved imaging agent for malignant melanoma, based on [Nle4,D-Phe7]alpha-melanocyte stimulating hormone.
_h[electronic resource]
260 _bNuclear medicine communications
_cOct 1995
300 _a860-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aIndium Radioisotopes
_xpharmacokinetics
650 0 4 _aMale
650 0 4 _aMelanocyte-Stimulating Hormones
_xpharmacokinetics
650 0 4 _aMelanoma, Experimental
_xdiagnostic imaging
650 0 4 _aMice
650 0 4 _aMice, Inbred DBA
650 0 4 _aMolecular Sequence Data
650 0 4 _aMonophenol Monooxygenase
_xmetabolism
650 0 4 _aNeoplasm Proteins
_xmetabolism
650 0 4 _aNeoplasm Transplantation
650 0 4 _aPentetic Acid
_xanalogs & derivatives
650 0 4 _aRadionuclide Imaging
650 0 4 _aTissue Distribution
650 0 4 _aTumor Cells, Cultured
773 0 _tNuclear medicine communications
_gvol. 16
_gno. 10
_gp. 860-6
856 4 0 _uhttps://doi.org/10.1097/00006231-199510000-00010
_zAvailable from publisher's website
999 _c8569191
_d8569191